ArticleJournal of clinical medicine2026

Better Outcomes After Initiation of Disease-Modifying Therapy in Patients with Transthyretin Cardiac Amyloidosis.

Makiko Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.